Cargando…
P735: EFFICACY AND SAFETY OF ORAL DECITABINE/CEDAZURIDINE (ASTX727) IN THE CMML SUBPOPULATION FROM PHASE 2 AND ASCERTAIN PHASE 3 STUDIES
| Autores principales: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Lippincott Williams & Wilkins
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10429272/ http://dx.doi.org/10.1097/01.HS9.0000969844.13426.20 |
| _version_ | 1785090670035206144 |
|---|---|
| author | Robert Savona, Michael K Mccloskey, James A. Griffiths, Elizabeth Yee, Karen M. Zeidan, Amer Al-Kali, Aref Joachim Deeg, H. A. Patel, Prapti Sabloff, Mitchell Keating, Mary-Margaret Y Zhu, Nancy Gabrail, Nashat Fazal, Salman J. Maly, Joseph Odenike, Olatoyosi Kantarjian, Hagop Dezern, Amy L Oconnell, Casey Roboz, Gail Busque, Lambert Buckstein, Rena Amin, Harshad K Randhawa, Jasleen Leber, Brian Dao, Kim-Hien Chan, Winny Oganesian, Aram Sano, Yuri Mirakhur, Beloo Keer, Harold Garcia-Manero, Guillermo |
| author_facet | Robert Savona, Michael K Mccloskey, James A. Griffiths, Elizabeth Yee, Karen M. Zeidan, Amer Al-Kali, Aref Joachim Deeg, H. A. Patel, Prapti Sabloff, Mitchell Keating, Mary-Margaret Y Zhu, Nancy Gabrail, Nashat Fazal, Salman J. Maly, Joseph Odenike, Olatoyosi Kantarjian, Hagop Dezern, Amy L Oconnell, Casey Roboz, Gail Busque, Lambert Buckstein, Rena Amin, Harshad K Randhawa, Jasleen Leber, Brian Dao, Kim-Hien Chan, Winny Oganesian, Aram Sano, Yuri Mirakhur, Beloo Keer, Harold Garcia-Manero, Guillermo |
| author_sort | Robert Savona, Michael |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-10429272 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | Lippincott Williams & Wilkins |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-104292722023-08-17 P735: EFFICACY AND SAFETY OF ORAL DECITABINE/CEDAZURIDINE (ASTX727) IN THE CMML SUBPOPULATION FROM PHASE 2 AND ASCERTAIN PHASE 3 STUDIES Robert Savona, Michael K Mccloskey, James A. Griffiths, Elizabeth Yee, Karen M. Zeidan, Amer Al-Kali, Aref Joachim Deeg, H. A. Patel, Prapti Sabloff, Mitchell Keating, Mary-Margaret Y Zhu, Nancy Gabrail, Nashat Fazal, Salman J. Maly, Joseph Odenike, Olatoyosi Kantarjian, Hagop Dezern, Amy L Oconnell, Casey Roboz, Gail Busque, Lambert Buckstein, Rena Amin, Harshad K Randhawa, Jasleen Leber, Brian Dao, Kim-Hien Chan, Winny Oganesian, Aram Sano, Yuri Mirakhur, Beloo Keer, Harold Garcia-Manero, Guillermo Hemasphere Posters Lippincott Williams & Wilkins 2023-08-08 /pmc/articles/PMC10429272/ http://dx.doi.org/10.1097/01.HS9.0000969844.13426.20 Text en Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially. |
| spellingShingle | Posters Robert Savona, Michael K Mccloskey, James A. Griffiths, Elizabeth Yee, Karen M. Zeidan, Amer Al-Kali, Aref Joachim Deeg, H. A. Patel, Prapti Sabloff, Mitchell Keating, Mary-Margaret Y Zhu, Nancy Gabrail, Nashat Fazal, Salman J. Maly, Joseph Odenike, Olatoyosi Kantarjian, Hagop Dezern, Amy L Oconnell, Casey Roboz, Gail Busque, Lambert Buckstein, Rena Amin, Harshad K Randhawa, Jasleen Leber, Brian Dao, Kim-Hien Chan, Winny Oganesian, Aram Sano, Yuri Mirakhur, Beloo Keer, Harold Garcia-Manero, Guillermo P735: EFFICACY AND SAFETY OF ORAL DECITABINE/CEDAZURIDINE (ASTX727) IN THE CMML SUBPOPULATION FROM PHASE 2 AND ASCERTAIN PHASE 3 STUDIES |
| title | P735: EFFICACY AND SAFETY OF ORAL DECITABINE/CEDAZURIDINE (ASTX727) IN THE CMML SUBPOPULATION FROM PHASE 2 AND ASCERTAIN PHASE 3 STUDIES |
| title_full | P735: EFFICACY AND SAFETY OF ORAL DECITABINE/CEDAZURIDINE (ASTX727) IN THE CMML SUBPOPULATION FROM PHASE 2 AND ASCERTAIN PHASE 3 STUDIES |
| title_fullStr | P735: EFFICACY AND SAFETY OF ORAL DECITABINE/CEDAZURIDINE (ASTX727) IN THE CMML SUBPOPULATION FROM PHASE 2 AND ASCERTAIN PHASE 3 STUDIES |
| title_full_unstemmed | P735: EFFICACY AND SAFETY OF ORAL DECITABINE/CEDAZURIDINE (ASTX727) IN THE CMML SUBPOPULATION FROM PHASE 2 AND ASCERTAIN PHASE 3 STUDIES |
| title_short | P735: EFFICACY AND SAFETY OF ORAL DECITABINE/CEDAZURIDINE (ASTX727) IN THE CMML SUBPOPULATION FROM PHASE 2 AND ASCERTAIN PHASE 3 STUDIES |
| title_sort | p735: efficacy and safety of oral decitabine/cedazuridine (astx727) in the cmml subpopulation from phase 2 and ascertain phase 3 studies |
| topic | Posters |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10429272/ http://dx.doi.org/10.1097/01.HS9.0000969844.13426.20 |
| work_keys_str_mv | AT robertsavonamichael p735efficacyandsafetyoforaldecitabinecedazuridineastx727inthecmmlsubpopulationfromphase2andascertainphase3studies AT kmccloskeyjames p735efficacyandsafetyoforaldecitabinecedazuridineastx727inthecmmlsubpopulationfromphase2andascertainphase3studies AT agriffithselizabeth p735efficacyandsafetyoforaldecitabinecedazuridineastx727inthecmmlsubpopulationfromphase2andascertainphase3studies AT yeekaren p735efficacyandsafetyoforaldecitabinecedazuridineastx727inthecmmlsubpopulationfromphase2andascertainphase3studies AT mzeidanamer p735efficacyandsafetyoforaldecitabinecedazuridineastx727inthecmmlsubpopulationfromphase2andascertainphase3studies AT alkaliaref p735efficacyandsafetyoforaldecitabinecedazuridineastx727inthecmmlsubpopulationfromphase2andascertainphase3studies AT joachimdeegh p735efficacyandsafetyoforaldecitabinecedazuridineastx727inthecmmlsubpopulationfromphase2andascertainphase3studies AT apatelprapti p735efficacyandsafetyoforaldecitabinecedazuridineastx727inthecmmlsubpopulationfromphase2andascertainphase3studies AT sabloffmitchell p735efficacyandsafetyoforaldecitabinecedazuridineastx727inthecmmlsubpopulationfromphase2andascertainphase3studies AT keatingmarymargaret p735efficacyandsafetyoforaldecitabinecedazuridineastx727inthecmmlsubpopulationfromphase2andascertainphase3studies AT yzhunancy p735efficacyandsafetyoforaldecitabinecedazuridineastx727inthecmmlsubpopulationfromphase2andascertainphase3studies AT gabrailnashat p735efficacyandsafetyoforaldecitabinecedazuridineastx727inthecmmlsubpopulationfromphase2andascertainphase3studies AT fazalsalman p735efficacyandsafetyoforaldecitabinecedazuridineastx727inthecmmlsubpopulationfromphase2andascertainphase3studies AT jmalyjoseph p735efficacyandsafetyoforaldecitabinecedazuridineastx727inthecmmlsubpopulationfromphase2andascertainphase3studies AT odenikeolatoyosi p735efficacyandsafetyoforaldecitabinecedazuridineastx727inthecmmlsubpopulationfromphase2andascertainphase3studies AT kantarjianhagop p735efficacyandsafetyoforaldecitabinecedazuridineastx727inthecmmlsubpopulationfromphase2andascertainphase3studies AT dezernamy p735efficacyandsafetyoforaldecitabinecedazuridineastx727inthecmmlsubpopulationfromphase2andascertainphase3studies AT loconnellcasey p735efficacyandsafetyoforaldecitabinecedazuridineastx727inthecmmlsubpopulationfromphase2andascertainphase3studies AT robozgail p735efficacyandsafetyoforaldecitabinecedazuridineastx727inthecmmlsubpopulationfromphase2andascertainphase3studies AT busquelambert p735efficacyandsafetyoforaldecitabinecedazuridineastx727inthecmmlsubpopulationfromphase2andascertainphase3studies AT bucksteinrena p735efficacyandsafetyoforaldecitabinecedazuridineastx727inthecmmlsubpopulationfromphase2andascertainphase3studies AT aminharshad p735efficacyandsafetyoforaldecitabinecedazuridineastx727inthecmmlsubpopulationfromphase2andascertainphase3studies AT krandhawajasleen p735efficacyandsafetyoforaldecitabinecedazuridineastx727inthecmmlsubpopulationfromphase2andascertainphase3studies AT leberbrian p735efficacyandsafetyoforaldecitabinecedazuridineastx727inthecmmlsubpopulationfromphase2andascertainphase3studies AT daokimhien p735efficacyandsafetyoforaldecitabinecedazuridineastx727inthecmmlsubpopulationfromphase2andascertainphase3studies AT chanwinny p735efficacyandsafetyoforaldecitabinecedazuridineastx727inthecmmlsubpopulationfromphase2andascertainphase3studies AT oganesianaram p735efficacyandsafetyoforaldecitabinecedazuridineastx727inthecmmlsubpopulationfromphase2andascertainphase3studies AT sanoyuri p735efficacyandsafetyoforaldecitabinecedazuridineastx727inthecmmlsubpopulationfromphase2andascertainphase3studies AT mirakhurbeloo p735efficacyandsafetyoforaldecitabinecedazuridineastx727inthecmmlsubpopulationfromphase2andascertainphase3studies AT keerharold p735efficacyandsafetyoforaldecitabinecedazuridineastx727inthecmmlsubpopulationfromphase2andascertainphase3studies AT garciamaneroguillermo p735efficacyandsafetyoforaldecitabinecedazuridineastx727inthecmmlsubpopulationfromphase2andascertainphase3studies |